Is SGHT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SGHT. It does not provide personalized investment advice.

SGHT (Sight Sciences, Inc. Common Stock) Stock Analysis - Financials

Sight Sciences, Inc. Common Stock (SGHT) is a publicly traded Healthcare sector company. As of September 21, 2026, SGHT trades at $8.29 with a market cap of $441.81M and a P/E ratio of -14.32. SGHT moved +3.49% today. Year to date, SGHT is +1.13%; over the trailing twelve months it is +117.34%. Its 52-week range spans $2.03 to $9.24. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces SGHT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SGHT's key financials?

SGHT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SGHT recently traded at $8.29. Market cap is $441.81M. P/E ratio is -14.32. Revenue is $83.38M.

SGHT Key Metrics

Key financial metrics for SGHT
Metric	Value
Price	$8.29
Market Cap	$441.81M
P/E Ratio	-14.32
EPS	$-0.56
Dividend Yield	0.00%
52-Week High	$9.24
52-Week Low	$2.03
Volume	140.84K
Avg Volume	0
Revenue (TTM)	$83.38M
Net Income	$-29.76M
Gross Margin	87.96%

SGHT Analyst Consensus

7 analysts cover SGHT: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about SGHT

What are SGHT's key financials?: SGHT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SGHT recently traded at $8.29. Market cap is $441.81M. P/E ratio is -14.32. Revenue is $83.38M.
Is SGHT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SGHT. It does not provide personalized investment advice.